Clark Lindgren - Publications

Affiliations: 
Grinnell College, Grinnell, IA, United States 
Area:
Neurobiology, Plasticity, Electrophysiology, Neuromuscular Junction

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wang JS, Bojovic D, Chen Y, Lindgren CA. Homocysteine sensitizes the mouse neuromuscular junction to oxidative stress by nitric oxide. Neuroreport. PMID 29939872 DOI: 10.1097/WNR.0000000000001073  0.84
2014 Grosu V, Lindgren C, Vejsz T, Chen YC, Bhunia A. Thermal management solutions for network file server used in avionics applications Proceedings - 2014 47th International Symposium On Microelectronics, Imaps 2014. 419-427.  0.56
2013 Lindgren CA, Newman ZL, Morford JJ, Ryan SB, Battani KA, Su Z. Cyclooxygenase-2, prostaglandin E2 glycerol ester and nitric oxide are involved in muscarine-induced presynaptic enhancement at the vertebrate neuromuscular junction. The Journal of Physiology. 591: 4749-64. PMID 23818695 DOI: 10.1113/jphysiol.2013.256727  1
2013 Walder KK, Ryan SB, Bzdega T, Olszewski RT, Neale JH, Lindgren CA. Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction. The European Journal of Neuroscience. 37: 118-29. PMID 23134476 DOI: 10.1111/ejn.12027  1
2012 Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE, Raubitschek A, Forman SJ, Greenberg PD, Riddell SR, Press OW. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood. 119: 3940-50. PMID 22308288 DOI: 10.1182/blood-2011-10-387969  0.4
2008 Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ, Gopal AK, Pagel JM, Lindgren CG, Greenberg PD, Riddell SR, et al. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood. 112: 2261-71. PMID 18509084 DOI: 10.1182/blood-2007-12-128843  0.4
2007 Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, ... ... Lindgren CM, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics. 39: 1329-37. PMID 17952073 DOI: 10.1038/ng.2007.17  0.64
2007 Wang J, Jensen M, Lin Y, Sui X, Chen E, Lindgren CG, Till B, Raubitschek A, Forman SJ, Qian X, James S, Greenberg P, Riddell S, Press OW. Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains. Human Gene Therapy. 18: 712-25. PMID 17685852 DOI: 10.1089/hum.2007.028  0.44
2007 Newman Z, Malik P, Wu TY, Ochoa C, Watsa N, Lindgren C. Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction. The European Journal of Neuroscience. 25: 1619-30. PMID 17408433 DOI: 10.1111/j.1460-9568.2007.05422.x  1
2004 Graves AR, Lewin KA, A Lindgren C. Nitric oxide, cAMP and the biphasic muscarinic modulation of ACh release at the lizard neuromuscular junction. The Journal of Physiology. 559: 423-32. PMID 15235096 DOI: 10.1113/jphysiol.2004.064469  1
2004 Wang J, Press OW, Lindgren CG, Greenberg P, Riddell S, Qian X, Laugen C, Raubitschek A, Forman SJ, Jensen MC. Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 577-86. PMID 15093188 DOI: 10.1016/j.ymthe.2003.12.011  0.44
1997 Fefer A, Robinson N, Benyunes MC, Bensinger WI, Press O, Thompson JA, Lindgren C. Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. The Cancer Journal From Scientific American. 3: S48-53. PMID 9457394  0.4
1997 Thompson JA, Gold PJ, Markowitz DR, Byrd DR, Lindgren CG, Fefer A. Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma. The Cancer Journal From Scientific American. 3: S29-34. PMID 9457390  0.4
1997 Lindgren CG, Thompson JA, Robinson N, Keeler T, Gold PJ, Fefer A. Interleukin-12 induced cytolytic activity in lymphocytes from recipients of autologous and allogeneic stem cell transplants. Bone Marrow Transplantation. 19: 867-73. PMID 9156259 DOI: 10.1038/sj.bmt.1700774  0.4
1997 Lindgren CA, Emery DG, Haydon PG. Intracellular acidification reversibly reduces endocytosis at the neuromuscular junction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 3074-84. PMID 9096142  1
1997 Robinson N, Benyunes MC, Thompson JA, York A, Petersdorf S, Press O, Lindgren C, Chauncey T, Buckner CD, Bensinger WI, Appelbaum FR, Fefer A. Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplantation. 19: 435-42. PMID 9052908 DOI: 10.1038/sj.bmt.1700687  0.4
1996 Robinson N, Sanders JE, Benyunes MC, Beach K, Lindgren C, Thompson JA, Appelbaum FR, Fefer A. Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia. Blood. 87: 1249-54. PMID 8608212  0.4
1995 Benyunes MC, Higuchi C, York A, Lindgren C, Thompson JA, Buckner CD, Fefer A. Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. Bone Marrow Transplantation. 16: 283-8. PMID 7581149  0.4
1994 Kovach NL, Lindgren CG, Fefer A, Thompson JA, Yednock T, Harlan JM. Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells. Blood. 84: 2234-42. PMID 7919341  0.4
1994 Neubauer MA, Benyunes MC, Thompson JA, Bensinger WI, Lindgren CG, Buckner CD, Fefer A. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation. 13: 311-6. PMID 7911048  0.4
1994 Lindgren CA, Laird MV. Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction. Neuroreport. 5: 2205-8. PMID 7865778  1
1993 Fefer A, Benyunes M, Higuchi C, York A, Massumoto C, Lindgren C, Buckner CD, Thompson JA. Interleukin-2 +/- lymphocytes as consolidative immunotherapy after autologous bone marrow transplantation for hematologic malignancies. Acta Haematologica. 89: 2-7. PMID 8475668 DOI: 10.1159/000204577  0.4
1993 Pavletic Z, Benyunes MC, Thompson JA, Lindgren CG, Massumoto C, Alderson MR, Buckner CD, Fefer A. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy. Experimental Hematology. 21: 1371-8. PMID 8359237  0.4
1993 Thompson JA, Lindgren CG, Benyunes MC, Bianco JA, Shields AF, Fefer A. The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 13: 84-90. PMID 8318500  0.4
1993 Lindgren CG, Thompson JA, Higuchi CM, Fefer A. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 14: 322-8. PMID 8280715  0.4
1992 Lindgren CC, Dasgupta PK. Flow injection and solvent extraction with intelligent segment separation. Determination of quaternary ammonium ions by ion-pairing. Talanta. 39: 101-11. PMID 18965347  1
1992 Thompson JA, Shulman KL, Benyunes MC, Lindgren CG, Collins C, Lange PH, Bush WH, Benz LA, Fefer A. Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 10: 960-8. PMID 1588376  0.4
1991 Lindgren CA, Moore JW. Calcium current in motor nerve endings of the lizard. Annals of the New York Academy of Sciences. 635: 58-69. PMID 1683760  1
1990 Treisman J, Higuchi CM, Thompson JA, Gillis S, Lindgren CG, Kern DE, Ridell SR, Greenberg PD, Fefer A. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients. Cancer Research. 50: 1160-4. PMID 2153452  0.4
1989 Thompson JA, Lee DJ, Lindgren CG, Benz LA, Collins C, Shuman WP, Levitt D, Fefer A. Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells. Cancer Research. 49: 235-40. PMID 2783243  0.4
1989 Lindgren CA, Moore JW. Identification of ionic currents at presynaptic nerve endings of the lizard. The Journal of Physiology. 414: 201-22. PMID 2575161  1
1989 Higuchi CM, Thompson JA, Lindgren CG, Gillis S, Widmer MB, Kern DE, Fefer A. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. Cancer Research. 49: 6487-92. PMID 2479463  0.4
1989 Higuchi CM, Thompson JA, Cox T, Lindgren CG, Buckner CD, Fefer A. Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies. Cancer Research. 49: 5509-13. PMID 2477142  0.4
1989 Dunlap K, Holz GG, Lindgren CA, Moore JW. Calcium channels that regulate neurosecretion. Society of General Physiologists Series. 44: 239-50. PMID 2476855  1
1988 Thompson JA, Lee DJ, Lindgren CG, Benz LA, Collins C, Levitt D, Fefer A. Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 669-78. PMID 3258631  0.4
1987 Lindgren CA, Smith DO. Extracellular ATP modulates calcium uptake and transmitter release at the neuromuscular junction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 1567-73. PMID 3572490  1
1987 Thompson JA, Lee DJ, Cox WW, Lindgren CG, Collins C, Neraas KA, Dennin RA, Fefer A. Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial. Cancer Research. 47: 4202-7. PMID 3496957  0.4
1987 Thompson JA, Cox WW, Lindgren CG, Collins C, Neraas KA, Bonnem EM, Fefer A. Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects. Cancer Immunology, Immunotherapy : Cii. 25: 47-53. PMID 3109737  0.4
1987 Ilowite NT, Wedgwood RJ, Rose LM, Clark EA, Lindgren CG, Ochs HD. Impaired in vivo and in vitro antibody responses to bacteriophage phi X 174 in juvenile rheumatoid arthritis. The Journal of Rheumatology. 14: 957-63. PMID 2963130  0.4
1986 Lindgren CA, Smith DO. Increased presynaptic ATP levels coupled to synaptic activity at the crayfish neuromuscular junction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 2644-52. PMID 3018197  1
1983 Ochs HD, Kraemer MJ, Lindgren CG, Furukawa CT, Wedgwood RJ. Immune regulation in the hyper-IgE/Job syndrome. Birth Defects Original Article Series. 19: 57-61. PMID 6360246  0.4
1982 Auerbach R, Alby L, Grieves J, Joseph J, Lindgren C, Morrissey LW, Sidky YA, Tu M, Watt SL. Monoclonal antibody against angiotensin-converting enzyme: its use as a marker for murine, bovine, and human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 79: 7891-5. PMID 6296854 DOI: 10.1073/pnas.79.24.7891  0.4
Show low-probability matches.